General Hospital Elche
Elche, Alicante, 03203, Spain
NCT Number: NCT02122874
Percutaneous neurostimulation of dermatome T7 increases Insulin segregation by the apancreas and improves glycemic profile in diabetic patients
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Elche, Alicante, 03203, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The patients undergo PENS of dermatome T7 and follow a 1200 Kcal diet
Time frame: Baseline and 12 weeks after beginning the therapy
Serum glucose levels will be recorded will be recorded at baseline and 12 weeks after beginning the treatment. Measurement units will be mg/dl.
Time frame: Baseline and 12 weeks after beginning the therapy
Insulin resistance will be recorded by the Homeostasis model assessment (HOMA). The calculation formula is: Serum Glucose x Serum Insulin / 405
Hospital General Universitario Elche
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05887271
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial DetailsNCT06106035
Diabetes Mellitus, Diabetes Mellitus Type 2 in Obese
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06235762
COVID-19, Cardiovascular Diseases
São José do Rio Preto, São Paulo, Brazil
View Trial DetailsNCT01364350
Diabetes Mellitus, Diabetes Mellitus Type 2 in Obese
Los Angeles, California, United States
View Trial Details